GlassScriptPhysician profile
John P Belardo
NPI 1720196314
$12,096.46
in general payments reported to CMS, 2019-2025
18 companies · $3,767 in 2025
The $3,767 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,738 · 2020: $388 · 2021: $3,326 · 2022: $501 · 2023: $469 · 2024: $907 · 2025: $3,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $2,118 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,117.53 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $3,412.10 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Biotissue Holdings INC. | $3,386.81 | 2019-2021 | |
| Alcon Vision LLC | $1,807.00 | 2019-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Carl Zeiss Meditec, INC. | $1,086.55 | 2021 | |
| Bausch & Lomb Americas INC. | $600.31 | 2022-2025 | Envista Mx60 Iol, Stellaris, Ic-8 Apthera Iol |
| Glaukos Corporation | $571.25 | 2020-2025 | Istent Infinite, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Staar Surgical Company | $266.39 | 2019 | |
| New World Medical,INC. | $190.73 | 2019-2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Johnson & Johnson Surgical Vision, INC. | $152.12 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $137.53 | 2019 | |
| Ivantis, INC | $136.52 | 2019 | |
| Sight Sciences, INC. | $120.10 | 2019-2023 | Omni Surgical System |
| Abbvie INC. | $93.95 | 2024 | |
| Eyevance Pharmaceuticals LLC | $38.66 | 2020 | |
| Allergan, INC. | $30.30 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $28.31 | 2024 | Tyrvaya |
| The Cameron-Ehlen Group, INC. | $24.31 | 2021 | |
| Tearlab Corp | $13.52 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Belardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.